- 3-methylglutaconic aciduria type II
- MGA type II
- Cardioskeletal myopathy with neutropenia and abnormal mitochondria
- TAZ defect
News & Events
On this page
NCATS Co-Sponsored Conferences
Nutritional Interventions in Primary Mitochondrial Disorders: Developing an Evidence Base, Tuesday, December 02, 2014 - Wednesday, December 03, 2014
Location: NIH Campus, Bethesda, MD
Description: The goal of this meeting is to explore the use of nutritional interventions, including dietary supplements, in primary mitochondrial disorders (PMD); identify gaps in knowledge; develop a research agenda; and identify research opportunities to promote an evidence base for the use of nutritional interventions in primary mitochondrial disorders.
Scientific and Medical Conference about Barth Syndrome, Thursday, June 26, 2014 - Friday, June 27, 2014
Location: Hilton Clearwater Beach Hotel, , Clearwater, FL
Description: <p>The main objective of the conference is translation of scientific advances discussed at this Conference into therapy for rare diseases like BTHS.<span> </span>The strategy is to assemble interested physicians/researchers to communicate experimental results and clinical findings and stimulate new work, collaborations, and publications.<span> </span>This Conference also provides a forum for critically discussing clinical advances or potential treatments.</p>
2013 Neurobiology of Disease in Children Symposium: Mitochondrial Disease, Wednesday, October 30, 2013 - Wednesday, October 30, 2013
Location: Austin, TX
Description: The topic for the 2013 NDC Symposium is Mitochondrial Disease. The NDC Symposium is a forum for preeminent investigators assembled to discuss recent accomplishments and future directions with a large group of child neurologists, program officers from the National Institutes of Health, and members of dedicated foundations and associations.
Scientific and Medical Meeting about Barth Syndrome , Thursday, July 29, 2010 - Friday, July 30, 2010
Location: Panama City Beach, Florida
Description: The anticipated outcomes of this meeting series were increased collaborations among the participants; an outline of future research strategy, focused on finding a treatment for Barth syndrome; in-depth evaluations of approaches to the treatment of Barth syndrome; and increased communication and publication of material directly relevant to Barth syndrome.